Advertisement

Impurity Rejection in the Crystallization of ABT-510 as a Method to Establish Starting Material Specifications

  • John C. Tolle
  • Calvin L. Becker
  • Jean C. Califano
  • Jane L. Chang
  • Kevin Gernhardt
  • James J. Napier
  • Steven J. Wittenberger
  • Judy Yuan
Part of the Advances in Experimental Medicine and Biology book series (volume 611)

Keywords

Process Development High Purity Primary Objective Crystallization Process Starting Material 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Henkin, J., Haviv, F., Bradley, M., Kalvin, D. and Schneider, A., JP 2002516342 WO 1999061476 (1999)Google Scholar
  2. 2.
    Sheikh, A., Pal, A., Viswanath, S. and Tolle, J., J. Pharm. Sci., published online 7 August 2007Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • John C. Tolle
    • 1
  • Calvin L. Becker
    • 1
  • Jean C. Califano
    • 1
  • Jane L. Chang
    • 1
  • Kevin Gernhardt
    • 1
  • James J. Napier
    • 1
  • Steven J. Wittenberger
    • 1
  • Judy Yuan
    • 1
  1. 1.Dept. R450Abbott Global Pharmaceutical Process R&DNorth ChicagoUSA

Personalised recommendations